Current reports
8-K
Sagimet Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
25 Mar 24
8-K
Departure of Directors or Certain Officers
2 Feb 24
8-K
Sagimet Biosciences Announces Pricing of Public Offering of Series A Common Stock
30 Jan 24
8-K
Results of Operations and Financial Condition
24 Jan 24
8-K
Regulation FD Disclosure
22 Jan 24
8-K
Departure of Directors or Certain Officers
29 Dec 23
8-K
Departure of Directors or Certain Officers
21 Nov 23
8-K
Sagimet Biosciences Reports Third Quarter 2023 Financial Results and Provides Corporate Updates
13 Nov 23
8-K
Regulation FD Disclosure
23 Oct 23
8-K
Regulation FD Disclosure
27 Sep 23
Registration and prospectus
S-8
Registration of securities for employees
25 Mar 24
424B4
Prospectus supplement with pricing info
29 Jan 24
S-1/A
IPO registration (amended)
24 Jan 24
S-1
IPO registration
23 Jan 24
DRS
Draft registration statement
10 Jan 24
S-8
Registration of securities for employees
17 Jul 23
424B4
Prospectus supplement with pricing info
14 Jul 23
S-1MEF
Registration of additional securities for an S-1
13 Jul 23
8-A12B
Registration of securities on exchange
11 Jul 23
S-1/A
IPO registration (amended)
10 Jul 23
Other
EFFECT
Notice of effectiveness
26 Jan 24
CORRESP
Correspondence with SEC
23 Jan 24
CORRESP
Correspondence with SEC
23 Jan 24
UPLOAD
Letter from SEC
16 Jan 24
EFFECT
Notice of effectiveness
14 Jul 23
SEC STAFF
SEC staff action: Order
14 Jul 23
CERT
Certification of approval for exchange listing
13 Jul 23
CORRESP
Correspondence with SEC
11 Jul 23
CORRESP
Correspondence with SEC
11 Jul 23
CORRESP
Correspondence with SEC
10 Jul 23
Ownership
4
Timothy P Walbert
3 Apr 24
4
Paul W. Hoelscher
3 Apr 24
3
Timothy P Walbert
3 Apr 24
3
Paul W. Hoelscher
3 Apr 24
4
David Happel
28 Mar 24
SC 13G/A
FMR LLC
11 Mar 24
SC 13G
NEW ENTERPRISE ASSOCIATES 13 LP
14 Feb 24
SC 13G
HILLHOUSE INVESTMENT MANAGEMENT, LTD.
14 Feb 24
SC 13G
BAKER BROS. ADVISORS LP
14 Feb 24
SC 13G
KPCB PANDEMIC & BIO DEFENSE FUND LLC
14 Feb 24